Edimer Pharmaceuticals, which was researching the recombinant protein EDI200 to cure XLinked Hypohydriotic Ectodermal Dysplasia XLHED), has unfortunately ceased its work. The good news comes from Germany, where Professor Holm Schneider, with the support of the hospital where he practices in Erlangen, Germany, is continuing his own work to find a cure for XLHED. Monies […]
Read More…